337 related articles for article (PubMed ID: 26614904)
21. Chemoimmunotherapy for hairy cell leukemia.
Ravandi F
Best Pract Res Clin Haematol; 2015 Dec; 28(4):230-5. PubMed ID: 26614901
[TBL] [Abstract][Full Text] [Related]
22. Historical overview of hairy cell leukemia.
Andritsos LA; Grever MR
Best Pract Res Clin Haematol; 2015 Dec; 28(4):166-74. PubMed ID: 26614894
[TBL] [Abstract][Full Text] [Related]
23. Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index.
Tallman MS; Hakimian D; Dyrda S; Kiley C; Nemcek A; Peterson L
Leuk Lymphoma; 1994; 14 Suppl 1():133-8. PubMed ID: 7529609
[TBL] [Abstract][Full Text] [Related]
24. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
Troussard X; Maître E; Paillassa J
Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
[TBL] [Abstract][Full Text] [Related]
25. Hairy cell leukaemia: biological and clinical overview from immunogenetic insights.
Forconi F
Hematol Oncol; 2011 Jun; 29(2):55-66. PubMed ID: 21674564
[TBL] [Abstract][Full Text] [Related]
26. Clinical presentations and complications of hairy cell leukemia.
Hoffman MA
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1065-73. PubMed ID: 16990107
[TBL] [Abstract][Full Text] [Related]
27. Update on the biology and treatment options for hairy cell leukemia.
Jain P; Pemmaraju N; Ravandi F
Curr Treat Options Oncol; 2014 Jun; 15(2):187-209. PubMed ID: 24652320
[TBL] [Abstract][Full Text] [Related]
28. Cladribine in hairy cell leukemia.
Belani R; Saven A
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
[TBL] [Abstract][Full Text] [Related]
29. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
[TBL] [Abstract][Full Text] [Related]
30. [Successful alemtuzumab treatment of a patient with atypical hairy cell leukaemia variant].
Telek B; Batár P; Udvardy M
Orv Hetil; 2007 Sep; 148(38):1805-7. PubMed ID: 17872336
[TBL] [Abstract][Full Text] [Related]
31. Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine--a report of three cases.
Blasińska-Morawiec M; Robak T; Krykowski E; Hellmann A; Urbańska-Ryś H
Leuk Lymphoma; 1997 Apr; 25(3-4):381-5. PubMed ID: 9168448
[TBL] [Abstract][Full Text] [Related]
32. Treatment of hairy cell leukemia-variant with cladribine.
Tetreault SA; Robbins BA; Saven A
Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
[TBL] [Abstract][Full Text] [Related]
33. New rearrangement pattern after treatment of hairy-cell leukemia with 2-chlorodeoxyadenosine.
Schirmer M; Haun M; Grünewald K; Geisen F; Hilbe W; Thaler J; Konwalinka G
Acta Haematol; 2000; 103(2):109-11. PubMed ID: 10838455
[TBL] [Abstract][Full Text] [Related]
34. Hairy cell leukemia: current concepts.
Cannon T; Mobarek D; Wegge J; Tabbara IA
Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of hairy cell leukemia variant with rituximab.
Narat S; Gandla J; Dogan A; Mehta A
Leuk Lymphoma; 2005 Aug; 46(8):1229-32. PubMed ID: 16085567
[TBL] [Abstract][Full Text] [Related]
36. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
Urasiński I; Zdziarska B; Krygier-Stojałowska A
Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
[TBL] [Abstract][Full Text] [Related]
37. Hairy cell leukemia: update and current therapeutic approach.
Salam L; Abdel-Wahab O
Curr Opin Hematol; 2015 Jul; 22(4):355-61. PubMed ID: 26049757
[TBL] [Abstract][Full Text] [Related]
38. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
Troussard X; Maître E; Cornet E
Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
[TBL] [Abstract][Full Text] [Related]
39. Molecular evaluation of clonal remission in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
di Celle PF; Reato G; Raspadori D; Carbone A; Rondelli D; Lauria F; Foà R
Leuk Lymphoma; 1994; 14 Suppl 1():139-42. PubMed ID: 7820046
[TBL] [Abstract][Full Text] [Related]
40. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
